Last reviewed · How we verify
Precision Dose - Ibuprofen oral suspension
Precision Dose - Ibuprofen oral suspension is a Small molecule drug developed by Hamilton Health Sciences Corporation. It is currently in Phase 2 development.
At a glance
| Generic name | Precision Dose - Ibuprofen oral suspension |
|---|---|
| Sponsor | Hamilton Health Sciences Corporation |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Precision Dose - Ibuprofen oral suspension CI brief — competitive landscape report
- Precision Dose - Ibuprofen oral suspension updates RSS · CI watch RSS
- Hamilton Health Sciences Corporation portfolio CI
Frequently asked questions about Precision Dose - Ibuprofen oral suspension
What is Precision Dose - Ibuprofen oral suspension?
Precision Dose - Ibuprofen oral suspension is a Small molecule drug developed by Hamilton Health Sciences Corporation.
Who makes Precision Dose - Ibuprofen oral suspension?
Precision Dose - Ibuprofen oral suspension is developed by Hamilton Health Sciences Corporation (see full Hamilton Health Sciences Corporation pipeline at /company/hamilton-health-sciences-corporation).
What development phase is Precision Dose - Ibuprofen oral suspension in?
Precision Dose - Ibuprofen oral suspension is in Phase 2.